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Abstract
Background: We evaluated effects of botulinum toxin A (Botox) and cast immobilization on tendon healing in a rat
model. Injection of Botox into rat supraspinatus was hypothesized to reduce muscle active force and improved
healing.
Methods: Eighty-four supraspinatus tendons were surgically transected and repaired in 42 Sprague-Dawley rats
(transosseous technique). After repair, supraspinatus muscle was injected with saline or Botox (3 or 6 U/kg). Half the
shoulders were cast-immobilized for the entire postoperative period; half were allowed free cage activity. Histology
was examined at 2, 4, 8, and 12 weeks. A healing zone cross-sectional area was measured, and biomechanical
testing of repair strength and tendon viscoelastic properties was conducted at 4 and 12 weeks.
Results: Botox alone and cast immobilization alone exhibited increased ultimate load compared with controls
(saline injection, no immobilization) at 4 weeks. No difference in ultimate load occurred between Botox-only
and cast-only groups. At 12 weeks, the Botox (6 U/kg) plus cast immobilization group was significantly weakest
(p < 0.05). A trend was shown toward decreased healing zone cross-sectional areas in casted groups.
Conclusions: Supraspinatus Botox injection after rotator cuff repair might help protect the repair. However, cast
immobilization plus Botox administration is harmful to rotator cuff healing in a rat tendon model.
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Background
Rotator cuff disorders account for 10 % of all shoulder
pain in today’s aging population. Direct costs for shoul-
der treatment in the United States in the year 2000
reached US$7 billion, with no sign of this trend revers-
ing [1]. Rates of re-rupture are as high as 90 %, depend-
ing on type of imaging, and some rotator cuff repairs do
not heal [2]. When the rotator cuff does not heal after a
repair, pain might be decreased initially but function and
strength decline [2, 3].
Predictive factors that place a repair at risk include
patient age, tear size, time from injury to repair, and
postoperative activity level [4]. Various protocols of
immobilization have been recommended to allow the
rotator cuff to heal after repair without jeopardizing the
long-term range of motion of the shoulder, but this tenet
has been controversial [5]. Most surgeons have preferred
initial immobilization, passive range of motion, and
gradual progression to active assisted range of motion
[6]. Because of patient compliance issues and biological
challenges [7–10], optimizing the postoperative mechan-
ical environment remains difficult.
Botulinum toxin A (Botox; Allergan, Inc., Irvine, CA)
has been explored as a means of complete paralytic in-
ternal immobilization or “bioprotection” [11–13] in the
setting of Achilles tendon and rotator cuff healing. Our
purpose was to examine rotator cuff healing with intra-
muscular Botox injection in comparison with strict
immobilization and with a non-immobilized saline con-
trol. We explored this question using two low doses of
botulinum toxin A: 3 and 6 U/kg. The main objective
was to learn whether a single Botox injection obviates
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the need for cast immobilization in a rodent rotator cuff
injury model.
We hypothesized that botulinum toxin A injection
into the rat supraspinatus muscle reduces the muscle’s
active contractile force, allowing for improved healing at
the supraspinatus footprint. Although no consensus has
been reached regarding what “healing” truly is, we
adapted the concept of a healing zone or the area of scar
formation as healed to the greater tuberosity footprint.
Methods
Animal model
All animal procedures were approved by the Institu-
tional Animal Care and Use Committee at the University
of Maryland. Bilateral supraspinatus tendons of 42
male Sprague-Dawley skeletally immature rats (weight,
400–450 g) were surgically transected and repaired
with a transosseous technique based on a well-established
protocol [14–16]. Bilateral rotator cuff surgery has been
standardized in multiple animal protocols [17, 18].
The animals were anesthetized with 5 % isoflurane in-
duction and 2 % isoflurane maintenance delivered in an
oxygen mixture via face masks. After clipping and sterile
preparation were completed, a 1-cm incision was made
over the posterior aspect of the shoulder. The postero-
lateral aspect of the deltoid was removed from the acro-
mion. The supraspinatus was exposed with adduction of
the extremity and forearm supination. A 5.0 Prolene su-
ture (Ethicon, Somerville, NJ) was passed once through
the supraspinatus for traction. The tendon was sharply
transected with a No. 15 blade and firmly secured with
completion of a locking stitch using a modified Mason-
Allen technique. The anatomic footprint was burred at
high speed, and a 0.5-mm drill hole was aimed in a
cranial-caudal direction. The suture was passed through
the drill hole and tied with the supraspinatus reapproxi-
mated to its anatomic footprint on the greater tuberos-
ity. This rat injury model is analogous to an acute
rotator cuff tear and not a chronic tear.
Rat shoulders were randomly allocated by a random-
number generator into six experimental groups (Fig. 1),
ensuring one shoulder for a cast and one to be free from
immobilization while housed in individual cages and
allowed free cage activity. A power analysis (Stata 11;
StataCorp LP, College Station, TX) that was conducted
based on pilot work assessing ultimate load revealed that
60 shoulders were needed in total to provide 80 % power
to detect a 30 % difference in ultimate load between
groups with a p value of 0.05. One shoulder in each
group was reserved for a strictly qualitative histological
evaluation. Five shoulders in each group underwent
biomechanic evaluation at 4 and 12 weeks, which was
the main quantitative outcome of the study. The
supraspinatus muscle was injected intraoperatively
with either saline or botulinum toxin A after repair.
The Botox dose administered was either 3 or 6 U/kg,
based on previous small-animal bioprotection litera-
ture [11, 12]. Dilutions were standardized and volume
was equal for all injections. The control group received sa-
line injection into the supraspinatus and no cast
immobilization. Half the shoulders remained in casts
throughout the postoperative period. One shoulder of
each animal was randomly allocated to an immobilized
treatment group and the contralateral shoulder to a non-
immobilized treatment group. All rats were thereby
subjected to a cast and the same physiological stress. A
unilateral shoulder was immobilized at 90° of forward
flexion and 20° of abduction, which is a position of neutral
weight bearing for the Sprague-Dawley rat. The paw and
forearm were not included in the cast, and the animal was
allowed to freely bear weight on both paws.
Analgesia (buprenorphine, 0.03 mg/kg, administered
every 12 h) was provided by animal care staff during the
immediate postoperative period. Animals were examined
daily for signs of distress and cast discomfort. Rats
underwent an obligatory cast change every other week.
All cast changes were performed with the animals under
anesthesia in a controlled fashion to prevent excessive
passive manipulation of the shoulder.
Animals were euthanized at 2, 4, 8, and 12 weeks after
rotator cuff repair. The entire supraspinatus muscle, ten-
don, and scar unit were harvested en bloc with the prox-
imal humerus. Visual inspection revealed no gross,
macroscopic repair failures. Histological analysis was
conducted at all time points. Biomechanical testing was
completed at the 4- and 12-week time points.
Histological analysis
Specimens from each experimental group and all time
points underwent histological analysis. Muscle tendon
units were fixed in 4 % paraformaldehyde overnight and
then underwent 2 days of gentle decalcification in 14 %
ethylenediaminetetraacetic acid. The specimens were
next embedded in paraffin, sectioned with a microtome
into 3- to 4-μm sections, and dried. Samples were
Fig. 1 Chart clarifies treatment groups. Shoulders in three of six
treatment (Tx) groups remained in casts during the entire
postoperative period. Btx = Botox
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stained with toluidine blue for fibrocartilage detection
and Masson trichrome blue for fibrous tissue detection.
Hematoxylin and eosin testing was conducted to assess
muscle cell morphology. Specimens were evaluated by a
blinded pathologist specifically for fat formation in the
muscle, collagen orientation in the repair, and the order
of fibrocartilage proliferation.
Biomechanical testing
Sixty shoulders from the 4- and 12-week groups were bio-
mechanically tested for repair strength and tendon visco-
elastic properties, as previously described [17–19]. The
acromion and deltoid were initially removed, and subper-
iosteal dissection of the supraspinatus from its fossa was
performed. The humerus and tendon were dissected free,
and all excess soft-tissue constraints were removed from
the humeral head. The humerus-tendon unit was stored
in phosphate-buffered saline at 4 °C overnight for testing
the next day. The insertion-site scar was measured with
digital calipers, and an approximate area was determined
by using an elliptical assumption: area = π × thickness ×
width. A three-dimensional scar volume was calculated
based on the elliptical area times the scar length.
The distal portion of the humerus was potted in poly-
methylmethacrylate. The tendon was then fixed between
two pieces of sand paper and was clamped at 90° to the
supraspinatus tendon (Fig. 2). Biomechanical testing was
conducted in a mini-materials testing machine (Electro-
Force TestBench system; Bose Corporation, Eden Prairie,
MN).
The biomechanics loading protocol was based on a
well-established model for testing rat rotator cuff repair
[12, 16]. Specimens were initially preloaded to 0.2 N,
and then 5 cycles of preconditioning were applied to a
strain of 5 %. The strain measurement was based on the
distance from the clamp to the tendon insertion. The
conditioning rate remained a constant 0.1 % per second
for examination of viscoelastic properties. The specimen
was then stress-relaxed at 5 % strain for 5 min. Tendons
were loaded to failure at a constant rate (0.1 % per sec-
ond). Stress was calculated as tensile force applied ÷ initial
calculated cross-sectional area. Stiffness was same force ÷
linear displacement, whereas the tendon-scar modulus
was extrapolated from the linear portion of the stress-
strain curve. Ultimate load and stress were determined
based on the point of failure. Anatomic location of failure
was recorded as one of three categories: tendon-scar inter-
face, scar-bone interface, or indeterminate (Fig. 3).
Statistical analysis
Biomechanical results were subjected to a two-factor
analysis of variance and a Tukey post hoc test to allow
for multiple-group analysis with all groups compared
with only the non-treated (no Botox or cast) group. Stat-
istical significance was set at p < 0.05. Anatomic site of
failure was strictly observational, and statistical analysis
was not conducted on histological results because they
were qualitative.
Results
Before euthanization, all animals survived the treatment
in good health. No adverse events occurred.
Histology
Muscle atrophy was observed on gross examination; fatty
infiltration was noted on a cellular level. The two groups
subjected to both Botox injection and immobilization ex-
hibited wasting in the supraspinatus fossa. The findings
were corroborated with histological findings of extensive
Fig. 2 Harvested sample is shown. Supraspinatus tendon (thick arrow)
is clamped at 90° to the humeral head (thin arrow) before load analysis
Fig. 3 Areas of failure. a Failure at the tendon-scar junction. b Failure
at the scar-bone interface. Bracket = scar, arrow = point of failure
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fat infiltration. Cast immobilization alone at 12 weeks
echoed similar results: atrophy shown on gross examin-
ation and fatty infiltration on histological examination.
At 2 and 4 weeks, Botox-only groups had no gross
supraspinatus atrophy but some fatty infiltration was
revealed by histological examination.
At 8 and 12 weeks, however, the Botox-only groups
had no fatty findings. At 2 weeks, all specimens demon-
strated a disorganized fibrocartilage scar at the tendon-
bone interface. At 8 and 12 weeks, no difference was
observed in scar organization among all groups. At 4 weeks,
shoulders subjected to Botox only, cast immobilization
only, or Botox plus cast immobilization showed a more
linear formation of collagen compared with the saline
control group (Fig. 4).
Biomechanics
The ultimate load of the repaired supraspinatus tendon in
the 4-week samples showed that the tendons receiving
either dose of Botox alone and those receiving cast
immobilization alone were significantly stronger than
those in the control group (p < 0.05). At 12 weeks, in-
creased load to failure was shown for the Botox-only
(6 U/kg dose) group compared with the cast-only
group and the saline-only control group (Fig. 5). Botox
(6 U/kg) in combination with cast immobilization was sig-
nificantly the weakest group at both time points (p < 0.05).
No statistical difference was observed in the healing
zone cross-sectional scar area or scar volume across
groups. The cast-only group at 12 weeks tended to have
decreased scar volume compared with the control group.
No difference in stiffness was observed at 4 weeks
(Fig. 6). Shoulders that received 6 U/kg Botox were the
least stiff compared with the 12-week groups and were
significantly different from control group shoulders at
the 12-week time point (p < 0.05). At 4 weeks, 21 (88 %)
of 24 repairs in the cast-only and Botox-only groups
combined failed at the scar-bone interface. All the saline
Fig. 4 Comparison of photomicrographs. a Non-immobilized saline control. b Botox 6 U/kg alone. c Cast alone. Masson’s trichrome blue stain
(original magnification, 10×) of scar at 4 weeks shows a disorganized scar for the non-immobilized control and a more organized scar for the
Botox-only and cast-only specimens. Rectangles indicate regions of interest
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control group repairs, however, failed at the tendon-scar
junction. At 12 weeks, gross inspection showed that all
specimens failed at the scar-bone interface.
Discussion
We assessed whether intraoperative Botox injection op-
timizes the early postoperative mechanical environment
in a rat rotator cuff healing model. We paralyzed the
supraspinatus with botulinum toxin A after rotator cuff
injury and repair. We used a lower dose of Botox than
that used in previous studies [11, 12] to allow some load
at the repair site. Half the shoulders were additionally
treated with immobilization, and the other half were
allowed free cage activity. Cast immobilization in com-
bination with 6 U/kg Botox paralysis impaired the repair
quality. Botox treatment combined with free cage activ-
ity provided repair strength similar to that provided by
immobilization. Some force at the repair site is necessary
for tendon healing. Early active motion has been shown
to be beneficial in preserving hand motion for flexor
tendon repairs without hampering the healing process
[20]. These positive effects of early motion result in a
decrease in adhesion formation but might not improve
the quality of the healing tissue [21]. Early motion also
Fig. 5 Bar chart depicts force. Ultimate load at 4 and 12 weeks. At 4 weeks, Botox-only and cast-only groups were significantly stronger than the
control group. At 12 weeks, Botox 6 U/kg was the strongest and 6 U/kg with cast immobilization was the weakest. Asterisk = significant
values (p < 0.05) after Tukey post hoc test. Error bars correspond to standard deviations
Fig. 6 Bar chart depicts stiffness. Shoulders that received 6 U/kg Botox were least stiff at 12 weeks compared with control group shoulders.
Asterisk = significant values (p < 0.05) after Tukey post hoc test. Error bars correspond to standard deviations
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has importance in enthesis healing. Increasing static ten-
sion has proved to be beneficial at the knee in medial
collateral ligament healing [22].
Immediate passive motion in rotator cuff models has
been shown to have a detrimental effect. Peltz et al. [23]
examined immediate passive motion versus strict
immobilization after rat rotator cuff repair. Although no
difference was observed in rotator cuff mechanical prop-
erties, the immediate motion group showed decreased
range of motion, likely from increased subacromial scar
formation. Shoulders that were immobilized exhibited
mechanical properties superior to those of exercised
shoulders [24].
Tendon healing benefits from temporary immobilization
and responds to early motion. Bedi et al. [25] showed that
delayed loading in anterior cruciate ligament reconstruc-
tion in a Sprague-Dawley rat model was the optimum
mechanical environment, better than both prolonged
immobilization and immediate loading. Our results echo
this “happy medium” theory. In our study, at 12 weeks, a
single intraoperative injection of Botox provided the best
mechanical environment. Botulinum toxin A provides
early internal immobilization through reversible chemical
paralysis. It is a natural poison that inhibits presynaptic
acetylcholine release. Most of the effect of botulinum
toxin A decreases after the first few weeks [26]. The repair
site is then subjected to some passive motion during the
early postoperative period and then active and passive mo-
tion while the rotator cuff tendons remodel.
Botulinum toxin impacts the local mechanical envir-
onment and might also affect local biology factors. Re-
cent literature has focused on the biology as the cause of
tenopathy and tendon re-tear rather than the stiffness of
the repair construct or other mechanical theories [27,
28]. Botox has been used clinically for chronic tendino-
pathies, including lateral epicondylitis [29, 30]. Multiple
mechanisms have been proposed, including reversible
paralysis of the common extensor to allow microtrauma
to heal versus modulation of local pain receptors. The
proposed mechanism of Botox-assisted rotator cuff heal-
ing is unknown. Şahin et al. [31] found improvements in
gait analysis after intramuscular Botox injection after
cuff repair. It is unknown, however, whether this is a
function of anti-nociceptive effects of Botox or improved
cuff healing.
Bioprotection with Botox has been studied in various
tendon-to-bone healing models. Ma et al. [11] explored
the use of Botox to decrease the initial active force of
the rat gastrocnemius muscle after an Achilles tendon
repair. Twitch and tetanus contractions decreased 25 to
50 % during the initial month but returned to baseline
measurements after 6 months. The spontaneous rupture
rate of repaired tendons was significantly lower at 1 and
3 weeks after repair (p = 0.007). Our acute model did not
evaluate the early failure rate of the rotator cuff repair
but rather the mechanical properties of the healing scar.
This is a limitation of the acute rat rotator cuff model as
opposed to the Achilles repair model. No re-tears occur
in the rat rotator cuff because it heals spontaneously and
quickly.
In 2009, botulinum toxin A-assisted bioprotection for
rotator cuff repair was assessed in a rat rotator cuff injury
model [12]. Galatz et al. [12] injected 9 U/kg Botox into
the supraspinatus muscle of rats after rotator cuff repair.
This group was compared with a cast immobilization con-
trol group and a group treated with both Botox and
immobilization. The combination of Botox and casting
proved to be detrimental to rotator cuff repair, especially
at 8 weeks, whereas immobilization alone was superior at
both 4 and 8 weeks.
We observed similar discouraging findings in a study of
chronic rabbit rotator cuff tears treated with intramuscu-
lar Botox [32]. The atrophic supraspinatus muscle was un-
able to overcome the denervating insult of Botox, leading
to an inferior repair. In the present study, we extended
one time point to 12 weeks and added lower dosage
groups of 6 U/kg and 3 U/kg to better judge recovery after
botulinum toxin paralysis. We found similar results when
combining paralysis with immobilization. Even with strict
immobilization, some eccentric contraction of the rotator
cuff occurs, allowing for some beneficial force at the repair
site. The addition of Botox paralysis decreases this force,
leading to decreased repair quality.
Botulinum toxin A alone, however, showed some im-
proved rotator cuff biomechanical properties in our study.
We used low Botox doses of 3 and 6 U/kg to reduce the
supraspinatus muscle active force. In addition, we ex-
tended our final end point to 12 weeks, allowing for the
rotator cuff repair to remodel further after the Botox effect
continued to wean. The maximal effect of the injection,
however, occurs approximately 1 week after injection. In
one study, the intramuscular injection was administered
1 week before the rat rotator cuff injury and repair. Histo-
logical organization of the scar was improved, especially
tears subjected to increased load [33].
In our study, histological examination of the repair site
showed no difference at the cellular response level. The
only appreciable histological difference was the scar
orientation at 4 weeks. Groups treated with some kind
of immobilization (cast or Botox) exhibited a more linear
scar response. The scar orientation at 4 weeks matched
the location of load to failure results. At 4 weeks, failure
in the saline control group occurred at a lower load and
at the tendon-scar junction. Failure in the cast-only and
Botox-only groups occurred at higher loads at the scar-
bone site. Biomechanical failure at the scar-bone inter-
face might be a sign of early remodeling when compared
with failure at the tendon-scar interface. At 12 weeks, a
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majority of the constructs showed a linear scar response
and failure at the scar-bone site.
This study used a well-established rat rotator cuff in-
jury model that included both cast immobilization
groups and a saline-only control group. The biomechan-
ical and histological protocols have been well described
[34], rendering our results comparable with those of
other rodent models. We studied multiple treatment
groups and varied the dose of botulinum toxin A. In
addition, we recorded the site of failure, which has not
been previously described in the literature. Our study
provides important information in the setting of an
acute rotator cuff tear model.
A limitation of this study was the acute repair model
in a quadruped. Rotator cuff repairs with healing diffi-
culties typically are chronic in nature. It is possible that
optimizing the mechanical environment with Botox
might not overcome the poor biological condition of
chronic rotator cuff degeneration. In addition, rotator
cuff muscles in the setting of a chronic tear exhibit base-
line fatty degeneration and atrophy [35, 36]. The additive
paralysis effect of Botox in this setting is unknown and
might cause a more deleterious fatty response, as previ-
ously shown [32]. The exact paralytic effect of Botox on
a small rat supraspinatus muscle is unknown without
specific functional muscle testing. Therefore, we are
unable to quantify the paralyzed “load” exacted on the
repair site.
The literature on the topic of botulinum toxin-
assisted rotator cuff repair is confusing. Multiple fac-
tors need to be considered, including timing of injec-
tion, acute versus chronic repair, combining chemical
paralysis with immobilization, and the species of the
animal model [12, 31–33]. Botox might have its best
effect when injected before an acute repair with minimal
immobilization. Testing in an animal model that exhibits
a clinically relevant incidence of re-tear would help to re-
solve a current controversy in the literature.
Conclusions
Botulinum toxin A injection into the supraspinatus might
obviate the need for postoperative immobilization. Chem-
ical paralysis in addition to cast immobilization reduces
load at the repair site and is harmful to rotator cuff repair.
Clinical implications include potentially decreased postop-
erative immobilization time, better long-term functional
outcomes, improved compliance, and reduced stiffness
with increased protection of tendon repair sites.
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